ISPOR - PSK9 PRIOR AUTHORIZATION FOR TOPICAL PSORIASIS TREATMENTS- IS IT COST-BENEFICIAL FOR MANAGED CARE?

Full Text

PSK9 PRIOR AUTHORIZATION FOR TOPICAL PSORIASIS TREATMENTS- IS IT COST-BENEFICIAL FOR MANAGED CARE?

Abstract

Authors

R Balkrishnan MJ Bhosle VN Joish SR Feldman

Back to Volume 10, Issue 6

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now